JPMorgan analyst Thomas Palmer raised the firm’s price target on Bunge (BG) to $107 from $95 and keeps an Overweight rating on the shares. The company reduced its 2025 earnings guidance for the Viterra acquisition and current industry trends by far less than anticipated, the analyst tells investors in a research note. The firm views the rally yesterday as warranted as sees further upside in the shares. Viterra’s earnings “seem to be in a better place than feared,” and Bunge can drive earnings growth over the next couple of years, contends JPMorgan.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG:
- Early notable gainers among liquid option names on October 15th
- Bunge Global Updates Reporting Post-Viterra Merger
- Bunge lowers FY25 adjusted EPS view to $7.30-$7.60 from $7.75
- Bunge Global Terminates Major Credit Agreements
- Trump Weekly: White House announces drug pricing deal with Pfizer